Supramolecular Systems for Gene and Drug Delivery

Dear Colleagues,Supramolecular systems (calixarenes, cyclodextrins, polymers, peptides, etc.) have attracted special attention due to their excellent therapeutic properties for biomedical applications such as gene and drug delivery. Numerous biomaterials-based supramolecular systems have been develo...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (218 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04305nam-a2201009z--4500
001 993545155304498
005 20231214133047.0
006 m o d
007 cr|mn|---annan
008 202205s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5680000000037650 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/81103 
035 |a (EXLCZ)995680000000037650 
041 0 |a eng 
100 1 |a Ostos, Francisco José  |4 edt 
245 1 0 |a Supramolecular Systems for Gene and Drug Delivery 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (218 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Dear Colleagues,Supramolecular systems (calixarenes, cyclodextrins, polymers, peptides, etc.) have attracted special attention due to their excellent therapeutic properties for biomedical applications such as gene and drug delivery. Numerous biomaterials-based supramolecular systems have been developed in the last decade for enhancing of biocompatibility and pharmacological activity. In particular, supramolecular nanomaterials are considered a hot research topic, because nanomedicine has become an interesting tool for the treatment of genetic diseases or cancer. Nevertheless, novel systems and their properties are being continuously studied, contributing to the development of efficient delivery systems.This Special Issue provides and highlights current progress in the use of the supramolecular systems for boosting gene and drug delivery. Preparation, characterization, and use of these systems, as well as the latest developments in this research field, are especially welcome.Authors are encorauged to submit original research articles and reviews in this promising research field. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Chemistry  |2 bicssc 
653 |a β-cyclodextrin-based nanosponge 
653 |a phenylethylamine 
653 |a 2-amino-4-(4-chlorophenyl)thiazole (AT) 
653 |a gold nanoparticles 
653 |a carrier of therapeutic agents 
653 |a ferritin 
653 |a drug delivery 
653 |a tumor targeting 
653 |a half-life extension 
653 |a PAMAM dendrimers 
653 |a folic acid 
653 |a mRNA 
653 |a gene expression 
653 |a long acting injectables 
653 |a poly(l-lactic acid) 
653 |a poly(butylene adipate) 
653 |a block copolymers 
653 |a aripiprazole 
653 |a microparticles 
653 |a sustained release 
653 |a cationic calix[4]arenes 
653 |a liposomes 
653 |a nucleic acids 
653 |a transfection efficiency 
653 |a doxorubicin 
653 |a encapsulation 
653 |a adenine-uracil base pair 
653 |a complementary hydrogen bonded drug carrier system 
653 |a controlled drug delivery 
653 |a supramolecular nanogels 
653 |a selective cytotoxicity 
653 |a supramolecular self-assembled ribbon-like structures (SRLS) 
653 |a Congo red (CR) 
653 |a doxorubicin (Dox) 
653 |a bovine serum albumin (BSA) 
653 |a immunoglobulin light chain λ (Lλ) 
653 |a heat aggregated immunoglobulins (HAI) 
653 |a dynamic light scattering (DLS) 
653 |a elution volume (Ve) 
653 |a multi-walled carbon nanotube 
653 |a photothermal therapy 
653 |a indocyanine green 
653 |a synergistic strategy 
653 |a cancer treatment 
653 |a targeted drug delivery 
653 |a pillararene 
653 |a host:guest 
653 |a supramolecular 
653 |a hydrophobic 
653 |a ITC 
653 |a NMR 
653 |a magnetoliposomes 
653 |a microfluidics 
653 |a oral drug delivery 
653 |a magnetite nanoparticles 
776 |z 3-0365-3377-X 
776 |z 3-0365-3378-8 
700 1 |a Lebrón, José Antonio  |4 edt 
700 1 |a López-Cornejo, Pilar  |4 edt 
700 1 |a Ostos, Francisco José  |4 oth 
700 1 |a Lebrón, José Antonio  |4 oth 
700 1 |a López-Cornejo, Pilar  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:41:18 Europe/Vienna  |f system  |c marc21  |a 2022-05-14 21:41:54 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337869080004498&Force_direct=true  |Z 5337869080004498  |b Available  |8 5337869080004498